A technique to get more information from the blood of cancer patients than previously possible has been developed.
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing.
Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children’s cancers faster and more accurately.
A simple blood test could pinpoint which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma
Scientists have developed a new way of looking at how tumours evolve in real-time and develop drug resistance by tracking changes in blood.
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology*.
A prostate antigen level test at age 60 appears to provide an indication of a man’s lifetime risk of being diagnosed and dying from prostate cancer.
Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood.
Doctors should warn men that prostate cancer testing may lead to anxiety and distress, say Cancer Research UK experts.